Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
Conference Program for 2022 the World Conference on Lung Cancer
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2137
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
ES05 - Oncogenic Alterations and Beyond - Novel Treatments
- 12:00 - 13:00
- 8/07/2022
- Location: Hall C2
- IASLC CME Accredited
- Type: Education Session
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Moderators:Caicun Zhou, Maximilian Johannes Hochmair
-
+
Session Moderator
12:00 - 12:00 | Presenter: Caicun Zhou
- Abstract
Loading... -
+
Session Moderator
12:00 - 12:00 | Presenter: Maximilian Johannes Hochmair
- Abstract
Loading... -
+
ES05.01 - Session Introduction
12:00 - 12:01 | Presenter: Caicun Zhou
- Abstract
Loading... -
+
ES05.02 - Session Introduction
12:01 - 12:02 | Presenter: Maximilian Johannes Hochmair
- Abstract
Loading... -
+
ES05.03 - Targeting Rarer Events in Known Targets: EGFR Exon20 (EGFR, HER2)
12:02 - 12:14 | Presenter: Giannis Mountzios
- Abstract
Loading... -
+
ES05.04 - All You Need to Know About KRAS
12:14 - 12:26 | Presenter: Odd Terje Brustugun
- Abstract
Loading... -
+
ES05.05 - Antibody-Drug Conjugates - Where We Stand Today?
12:26 - 12:38 | Presenter: Bob T. Li
- Abstract
Loading... -
+
ES05.06 - HRD/DDR in Lung Cancer: Role and Therapeutic Implications
12:38 - 12:50 | Presenter: Lauren Averett Byers
- Abstract
Loading... -
+
ES05.07 - Live Q&A
12:50 - 13:00
- Abstract
Loading...
-
+
IS13 - Industry Symposium Sponsored by Janssen Pharmaceuticals: Expanding Horizons for the Targeted Management of EGFR-Mutant NSCLC
- 13:15 - 14:15
- 8/07/2022
- Location: Strauss 3
- Not for CME Credit
- Type: Industry Symposium
- Track: N/A
-
+
IS13.04 - EGFR exon 20 Insertion Mutations: A New Target for an Old Mutation
13:32 - 13:47 | Presenter: Maximilian Johannes Hochmair
- Abstract
Loading...
-
+
EP02.01 - Early Stage Non-small Cell Lung Cancer - Biomarkers
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Early Stage Non-small Cell Lung Cancer - Biomarkers
-
+
EP02.01-008 - Clinicopathological Features of Rare but Targetable Mutations in Surgically Resected Lung Carcinomas
Presenter: Luka Brcic- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
-
+
EP08.02-122 - Real-world Experience with Capmatinib in MET Exon 14-mutated Non-small Cell Lung Cancer (RECAP)
Presenter: Oliver Illini- Abstract
Loading...
-
+
EP16.01 - Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
- 09:45 - 18:00
- 8/07/2022
- Location: Exhibit Hall - Hall B
- Not for CME Credit
- Type: E-Poster
- Track: Tumor Biology and Biomarkers - Immune Biology & Immunotherapy
-
+
EP16.01-015 - Introducing "BiomeOne" a Microbiome-based bBiomarker to Predict Immune Checkpoint Inhibitor Response in NSCLC 1patients
Presenter: Maximilian Johannes Hochmair- Abstract
Loading...
